Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
Abstract Breast cancer remains a common malignancy in women, but the take-up for breast cancer screening programs in Japan is still low, possibly due to its perceived inconvenience. TFF1 and TFF3 are expressed in both breast cancer tissue and normal breast. Serum trefoil proteins were reported as ca...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7f5616ea3e334be1b84c86db8b61e9d9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7f5616ea3e334be1b84c86db8b61e9d9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7f5616ea3e334be1b84c86db8b61e9d92021-12-02T12:30:37ZSerum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer10.1038/s41598-017-05129-y2045-2322https://doaj.org/article/7f5616ea3e334be1b84c86db8b61e9d92017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05129-yhttps://doaj.org/toc/2045-2322Abstract Breast cancer remains a common malignancy in women, but the take-up for breast cancer screening programs in Japan is still low, possibly due to its perceived inconvenience. TFF1 and TFF3 are expressed in both breast cancer tissue and normal breast. Serum trefoil proteins were reported as cancer screening markers for gastric, prostate, lung, pancreatic cancer and cholangio carcinoma. The purpose of this study was to examine whether serum trefoil proteins could be screening biomarkers for breast cancer. Serum trefoil proteins in 94 breast cancer patients and 84 health check females were measured by ELISA. Serum TFF1 and TFF3 were significantly higher and serum TFF2 was significantly lower in breast cancer patients. Area under the curve of receiver operating characteristic of TFF1, TFF2, and TFF3 was 0.69, 0.83, and. 0.72, respectively. AUC of the combination of TFF1, TFF2, and TFF3 was 0.96. Immunohistochemically, TFF1 expression was positive in 56.5% and TFF3 was positive in 73.9% of breast cancers, while TFF2 was negative in all tumors. Serum TFF1 had positive correlation with expression of TFF1 in breast cancer tissue. Serum concentrations of TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.Yuko IshibashiHiroshi OhtsuMasako IkemuraYasuko KikuchiTakayoshi NiwaKotoe NishiokaYoshihiro UchidaHirona MiuraSusumu AikouToshiaki GunjiNobuyuki MatsuhashiYasukazu OhmotoTakeshi SasakiYasuyuki SetoToshihisa OgawaKeiichiro TadaSachiyo NomuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yuko Ishibashi Hiroshi Ohtsu Masako Ikemura Yasuko Kikuchi Takayoshi Niwa Kotoe Nishioka Yoshihiro Uchida Hirona Miura Susumu Aikou Toshiaki Gunji Nobuyuki Matsuhashi Yasukazu Ohmoto Takeshi Sasaki Yasuyuki Seto Toshihisa Ogawa Keiichiro Tada Sachiyo Nomura Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| description |
Abstract Breast cancer remains a common malignancy in women, but the take-up for breast cancer screening programs in Japan is still low, possibly due to its perceived inconvenience. TFF1 and TFF3 are expressed in both breast cancer tissue and normal breast. Serum trefoil proteins were reported as cancer screening markers for gastric, prostate, lung, pancreatic cancer and cholangio carcinoma. The purpose of this study was to examine whether serum trefoil proteins could be screening biomarkers for breast cancer. Serum trefoil proteins in 94 breast cancer patients and 84 health check females were measured by ELISA. Serum TFF1 and TFF3 were significantly higher and serum TFF2 was significantly lower in breast cancer patients. Area under the curve of receiver operating characteristic of TFF1, TFF2, and TFF3 was 0.69, 0.83, and. 0.72, respectively. AUC of the combination of TFF1, TFF2, and TFF3 was 0.96. Immunohistochemically, TFF1 expression was positive in 56.5% and TFF3 was positive in 73.9% of breast cancers, while TFF2 was negative in all tumors. Serum TFF1 had positive correlation with expression of TFF1 in breast cancer tissue. Serum concentrations of TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer. |
| format |
article |
| author |
Yuko Ishibashi Hiroshi Ohtsu Masako Ikemura Yasuko Kikuchi Takayoshi Niwa Kotoe Nishioka Yoshihiro Uchida Hirona Miura Susumu Aikou Toshiaki Gunji Nobuyuki Matsuhashi Yasukazu Ohmoto Takeshi Sasaki Yasuyuki Seto Toshihisa Ogawa Keiichiro Tada Sachiyo Nomura |
| author_facet |
Yuko Ishibashi Hiroshi Ohtsu Masako Ikemura Yasuko Kikuchi Takayoshi Niwa Kotoe Nishioka Yoshihiro Uchida Hirona Miura Susumu Aikou Toshiaki Gunji Nobuyuki Matsuhashi Yasukazu Ohmoto Takeshi Sasaki Yasuyuki Seto Toshihisa Ogawa Keiichiro Tada Sachiyo Nomura |
| author_sort |
Yuko Ishibashi |
| title |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| title_short |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| title_full |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| title_fullStr |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| title_full_unstemmed |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer |
| title_sort |
serum tff1 and tff3 but not tff2 are higher in women with breast cancer than in women without breast cancer |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/7f5616ea3e334be1b84c86db8b61e9d9 |
| work_keys_str_mv |
AT yukoishibashi serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT hiroshiohtsu serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT masakoikemura serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT yasukokikuchi serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT takayoshiniwa serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT kotoenishioka serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT yoshihirouchida serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT hironamiura serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT susumuaikou serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT toshiakigunji serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT nobuyukimatsuhashi serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT yasukazuohmoto serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT takeshisasaki serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT yasuyukiseto serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT toshihisaogawa serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT keiichirotada serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer AT sachiyonomura serumtff1andtff3butnottff2arehigherinwomenwithbreastcancerthaninwomenwithoutbreastcancer |
| _version_ |
1718394345225191424 |